Jul 20, 2026 07:30AM
Jul 20, 2026 07:30AM
Jul 9, 2026 06:48AM
Jul 8, 2026 07:30AM
Jul 8, 2026 07:30AM
Jul 7, 2026 04:02PM
Jun 11, 2026 07:30AM Immunome doses first patient in Phase 1 trial of IM-1617 cancer drug
Jun 11, 2026 07:30AM
Jun 4, 2026 04:02PM
May 30, 2026 08:00AM
May 30, 2026 08:00AM
May 27, 2026 08:00AM
May 12, 2026 04:02PM
Apr 29, 2026 07:30AM Immunome submits drug application to FDA for desmoid tumor treatment
Apr 29, 2026 07:30AM
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM
Mar 3, 2026 04:02PM
Feb 5, 2026 09:26AM
Dec 16, 2025 12:18PM
Dec 16, 2025 07:20AM Immunome Inc. (IMNM) PT Raised to $35 at Guggenheim
Dec 15, 2025 07:00AM
Dec 15, 2025 07:00AM
Nov 17, 2025 07:08AM
Aug 6, 2025 04:05PM
Feb 11, 2025 08:30AM
Jan 13, 2025 08:00AM
Oct 29, 2024 08:00AM Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
Oct 18, 2024 08:00AM
Jul 25, 2024 08:00AM
Mar 26, 2024 08:00AM
Feb 20, 2024 08:00AM
Feb 6, 2024 08:00AM
Feb 6, 2024 08:00AM
Nov 9, 2023 08:00AM Immunome Reports Third Quarter 2023 Financial Results
Oct 3, 2023 08:05AM
Oct 3, 2023 08:00AM
Jun 29, 2023 09:01AM
Jun 29, 2023 09:00AM
May 23, 2023 04:07PM
May 23, 2023 04:05PM
May 5, 2023 08:00AM Immunome Reports First Quarter 2023 Financial Results
Mar 16, 2023 08:00AM
Mar 9, 2023 08:45AM
Feb 8, 2023 08:00AM
Jan 6, 2023 08:02AM
Jan 6, 2023 08:00AM
Jan 6, 2023 08:00AM
Nov 14, 2022 08:00AM Immunome Reports Third Quarter 2022 Financial Results
Nov 9, 2022 12:04PM

326,488 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All